A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)

Aminah Jatoi, Howard L. Ritter, Amylou Dueck, Phuong L. Nguyen, Daniel A. Nikcevich, Ronnie F. Luyun, Bassam I. Mattar, Charles L. Loprinzi

Research output: Contribution to journalArticlepeer-review

107 Scopus citations

Fingerprint

Dive into the research topics of 'A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Immunology and Microbiology